To examine the contribution of the MUC1/EGFR–ABCB1 axis to tumor chemoresistance, we treated the HeLa229/shCTL tumor-bearing mice with PTX in combination with verapamil or erlotinib. The gene discussed is EGFR; the disease is neoplasm.